Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Accumulated Expenses (2016 - 2021)

Marimed has reported Other Accumulated Expenses over the past 8 years, most recently at $2000.0 for Q4 2021.

  • Quarterly Other Accumulated Expenses fell 91.54% to $2000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2021, down 91.54% year-over-year, with the annual reading at $2000.0 for FY2021, 91.54% down from the prior year.
  • Other Accumulated Expenses was $2000.0 for Q4 2021 at Marimed, down from $23640.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.6 million in Q1 2020 and troughed at $2000.0 in Q4 2021.
  • The 4-year median for Other Accumulated Expenses is $541588.0 (2017), against an average of $713560.1.
  • The largest YoY upside for Other Accumulated Expenses was 660.32% in 2020 against a maximum downside of 97.25% in 2020.
  • A 4-year view of Other Accumulated Expenses shows it stood at $225000.0 in 2017, then surged by 281.41% to $858176.0 in 2019, then tumbled by 97.25% to $23640.0 in 2020, then tumbled by 91.54% to $2000.0 in 2021.
  • Per Business Quant, the three most recent readings for MRMD's Other Accumulated Expenses are $2000.0 (Q4 2021), $23640.0 (Q4 2020), and $1.5 million (Q3 2020).